| |
Raltegravir based post exposure prophylaxis (PEP): A safe, well tolerated alternative regimen (Glasgow 2012)
|
| |
| |
Reported by Jules Levin
Glasgow 2012 Nov 11-15
David Annandale MGPhC, MPharm (hons), Claire Richardson MGPhC, BPharm (hons), Martin Fisher FRCP, Daniel Richardson FRCP.
Brighton, UKBrighton and Sussex University Hospitals NHS Trust, Brighton, UK
| |
| |
| |
|
|
|
